The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Influenza ELISA Kits Market Research Report 2025
Synopsis
Influenza ELISA kits are enzyme-linked immunosorbent assay kits used for the detection and quantification of antigens specific to influenza viruses in biological samples. These kits utilize the ELISA method to identify the presence of influenza virus antigens, aiding in the diagnosis and monitoring of influenza infections. Influenza ELISA kits are essential tools in clinical settings for rapid and accurate detection of influenza viruses, enabling healthcare professionals to initiate appropriate treatment and infection control measures promptly.
The global Influenza ELISA Kits market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
The industry trend for Influenza ELISA kits is driven by the constant threat of influenza outbreaks and the need for effective diagnostic tools. With increasing global awareness of the impact of seasonal and pandemic influenza on public health, there is a growing demand for advanced ELISA kits that offer improved sensitivity, specificity, and rapid results. Manufacturers are focusing on developing innovative Influenza ELISA kits that can detect a range of influenza virus strains, including novel and highly pathogenic strains. The market for Influenza ELISA kits is expected to see continued growth as healthcare systems prioritize early detection and surveillance of influenza viruses.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Influenza ELISA Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza ELISA Kits.
The Influenza ELISA Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Influenza ELISA Kits market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza ELISA Kits manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
MyBioSource
XpressBio
Abbexa
Sino Biological
Novus Biologicals
Biorbyt
DEMEDITEC Diagnostics
Eagle Bioscience
Krishgen Biosystems
United States Biological
Abnova Corporation
IBL
Aviva Systems Biology
Biomatik
Segment by Type
IgM
IgG
Segment by Application
Hospital
Laboratory
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Influenza ELISA Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Influenza ELISA Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Influenza ELISA kits are enzyme-linked immunosorbent assay kits used for the detection and quantification of antigens specific to influenza viruses in biological samples. These kits utilize the ELISA method to identify the presence of influenza virus antigens, aiding in the diagnosis and monitoring of influenza infections. Influenza ELISA kits are essential tools in clinical settings for rapid and accurate detection of influenza viruses, enabling healthcare professionals to initiate appropriate treatment and infection control measures promptly.
The global Influenza ELISA Kits market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
The industry trend for Influenza ELISA kits is driven by the constant threat of influenza outbreaks and the need for effective diagnostic tools. With increasing global awareness of the impact of seasonal and pandemic influenza on public health, there is a growing demand for advanced ELISA kits that offer improved sensitivity, specificity, and rapid results. Manufacturers are focusing on developing innovative Influenza ELISA kits that can detect a range of influenza virus strains, including novel and highly pathogenic strains. The market for Influenza ELISA kits is expected to see continued growth as healthcare systems prioritize early detection and surveillance of influenza viruses.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Influenza ELISA Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza ELISA Kits.
The Influenza ELISA Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Influenza ELISA Kits market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza ELISA Kits manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
MyBioSource
XpressBio
Abbexa
Sino Biological
Novus Biologicals
Biorbyt
DEMEDITEC Diagnostics
Eagle Bioscience
Krishgen Biosystems
United States Biological
Abnova Corporation
IBL
Aviva Systems Biology
Biomatik
Segment by Type
IgM
IgG
Segment by Application
Hospital
Laboratory
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Influenza ELISA Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Influenza ELISA Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Influenza ELISA Kits Market Overview
1.1 Product Definition
1.2 Influenza ELISA Kits by Type
1.2.1 Global Influenza ELISA Kits Market Value Comparison by Type (2024-2030)
1.2.2 IgM
1.2.3 IgG
1.3 Influenza ELISA Kits by Application
1.3.1 Global Influenza ELISA Kits Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Global Influenza ELISA Kits Market Size Estimates and Forecasts
1.4.1 Global Influenza ELISA Kits Revenue 2019-2030
1.4.2 Global Influenza ELISA Kits Sales 2019-2030
1.4.3 Global Influenza ELISA Kits Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Influenza ELISA Kits Market Competition by Manufacturers
2.1 Global Influenza ELISA Kits Sales Market Share by Manufacturers (2019-2024)
2.2 Global Influenza ELISA Kits Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Influenza ELISA Kits Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Influenza ELISA Kits, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Influenza ELISA Kits, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Influenza ELISA Kits, Product Type & Application
2.7 Global Key Manufacturers of Influenza ELISA Kits, Date of Enter into This Industry
2.8 Global Influenza ELISA Kits Market Competitive Situation and Trends
2.8.1 Global Influenza ELISA Kits Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Influenza ELISA Kits Players Market Share by Revenue
2.8.3 Global Influenza ELISA Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Influenza ELISA Kits Market Scenario by Region
3.1 Global Influenza ELISA Kits Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Influenza ELISA Kits Sales by Region: 2019-2030
3.2.1 Global Influenza ELISA Kits Sales by Region: 2019-2024
3.2.2 Global Influenza ELISA Kits Sales by Region: 2025-2030
3.3 Global Influenza ELISA Kits Revenue by Region: 2019-2030
3.3.1 Global Influenza ELISA Kits Revenue by Region: 2019-2024
3.3.2 Global Influenza ELISA Kits Revenue by Region: 2025-2030
3.4 North America Influenza ELISA Kits Market Facts & Figures by Country
3.4.1 North America Influenza ELISA Kits Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Influenza ELISA Kits Sales by Country (2019-2030)
3.4.3 North America Influenza ELISA Kits Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Influenza ELISA Kits Market Facts & Figures by Country
3.5.1 Europe Influenza ELISA Kits Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Influenza ELISA Kits Sales by Country (2019-2030)
3.5.3 Europe Influenza ELISA Kits Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Influenza ELISA Kits Market Facts & Figures by Region
3.6.1 Asia Pacific Influenza ELISA Kits Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Influenza ELISA Kits Sales by Region (2019-2030)
3.6.3 Asia Pacific Influenza ELISA Kits Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Influenza ELISA Kits Market Facts & Figures by Country
3.7.1 Latin America Influenza ELISA Kits Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Influenza ELISA Kits Sales by Country (2019-2030)
3.7.3 Latin America Influenza ELISA Kits Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Influenza ELISA Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa Influenza ELISA Kits Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Influenza ELISA Kits Sales by Country (2019-2030)
3.8.3 Middle East and Africa Influenza ELISA Kits Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Influenza ELISA Kits Sales by Type (2019-2030)
4.1.1 Global Influenza ELISA Kits Sales by Type (2019-2024)
4.1.2 Global Influenza ELISA Kits Sales by Type (2025-2030)
4.1.3 Global Influenza ELISA Kits Sales Market Share by Type (2019-2030)
4.2 Global Influenza ELISA Kits Revenue by Type (2019-2030)
4.2.1 Global Influenza ELISA Kits Revenue by Type (2019-2024)
4.2.2 Global Influenza ELISA Kits Revenue by Type (2025-2030)
4.2.3 Global Influenza ELISA Kits Revenue Market Share by Type (2019-2030)
4.3 Global Influenza ELISA Kits Price by Type (2019-2030)
5 Segment by Application
5.1 Global Influenza ELISA Kits Sales by Application (2019-2030)
5.1.1 Global Influenza ELISA Kits Sales by Application (2019-2024)
5.1.2 Global Influenza ELISA Kits Sales by Application (2025-2030)
5.1.3 Global Influenza ELISA Kits Sales Market Share by Application (2019-2030)
5.2 Global Influenza ELISA Kits Revenue by Application (2019-2030)
5.2.1 Global Influenza ELISA Kits Revenue by Application (2019-2024)
5.2.2 Global Influenza ELISA Kits Revenue by Application (2025-2030)
5.2.3 Global Influenza ELISA Kits Revenue Market Share by Application (2019-2030)
5.3 Global Influenza ELISA Kits Price by Application (2019-2030)
6 Key Companies Profiled
6.1 MyBioSource
6.1.1 MyBioSource Company Information
6.1.2 MyBioSource Description and Business Overview
6.1.3 MyBioSource Influenza ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.1.4 MyBioSource Influenza ELISA Kits Product Portfolio
6.1.5 MyBioSource Recent Developments/Updates
6.2 XpressBio
6.2.1 XpressBio Company Information
6.2.2 XpressBio Description and Business Overview
6.2.3 XpressBio Influenza ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.2.4 XpressBio Influenza ELISA Kits Product Portfolio
6.2.5 XpressBio Recent Developments/Updates
6.3 Abbexa
6.3.1 Abbexa Company Information
6.3.2 Abbexa Description and Business Overview
6.3.3 Abbexa Influenza ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbexa Influenza ELISA Kits Product Portfolio
6.3.5 Abbexa Recent Developments/Updates
6.4 Sino Biological
6.4.1 Sino Biological Company Information
6.4.2 Sino Biological Description and Business Overview
6.4.3 Sino Biological Influenza ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sino Biological Influenza ELISA Kits Product Portfolio
6.4.5 Sino Biological Recent Developments/Updates
6.5 Novus Biologicals
6.5.1 Novus Biologicals Company Information
6.5.2 Novus Biologicals Description and Business Overview
6.5.3 Novus Biologicals Influenza ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novus Biologicals Influenza ELISA Kits Product Portfolio
6.5.5 Novus Biologicals Recent Developments/Updates
6.6 Biorbyt
6.6.1 Biorbyt Company Information
6.6.2 Biorbyt Description and Business Overview
6.6.3 Biorbyt Influenza ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biorbyt Influenza ELISA Kits Product Portfolio
6.6.5 Biorbyt Recent Developments/Updates
6.7 DEMEDITEC Diagnostics
6.7.1 DEMEDITEC Diagnostics Company Information
6.7.2 DEMEDITEC Diagnostics Description and Business Overview
6.7.3 DEMEDITEC Diagnostics Influenza ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.7.4 DEMEDITEC Diagnostics Influenza ELISA Kits Product Portfolio
6.7.5 DEMEDITEC Diagnostics Recent Developments/Updates
6.8 Eagle Bioscience
6.8.1 Eagle Bioscience Company Information
6.8.2 Eagle Bioscience Description and Business Overview
6.8.3 Eagle Bioscience Influenza ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Eagle Bioscience Influenza ELISA Kits Product Portfolio
6.8.5 Eagle Bioscience Recent Developments/Updates
6.9 Krishgen Biosystems
6.9.1 Krishgen Biosystems Company Information
6.9.2 Krishgen Biosystems Description and Business Overview
6.9.3 Krishgen Biosystems Influenza ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Krishgen Biosystems Influenza ELISA Kits Product Portfolio
6.9.5 Krishgen Biosystems Recent Developments/Updates
6.10 United States Biological
6.10.1 United States Biological Company Information
6.10.2 United States Biological Description and Business Overview
6.10.3 United States Biological Influenza ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.10.4 United States Biological Influenza ELISA Kits Product Portfolio
6.10.5 United States Biological Recent Developments/Updates
6.11 Abnova Corporation
6.11.1 Abnova Corporation Company Information
6.11.2 Abnova Corporation Description and Business Overview
6.11.3 Abnova Corporation Influenza ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Abnova Corporation Influenza ELISA Kits Product Portfolio
6.11.5 Abnova Corporation Recent Developments/Updates
6.12 IBL
6.12.1 IBL Company Information
6.12.2 IBL Description and Business Overview
6.12.3 IBL Influenza ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.12.4 IBL Influenza ELISA Kits Product Portfolio
6.12.5 IBL Recent Developments/Updates
6.13 Aviva Systems Biology
6.13.1 Aviva Systems Biology Company Information
6.13.2 Aviva Systems Biology Description and Business Overview
6.13.3 Aviva Systems Biology Influenza ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Aviva Systems Biology Influenza ELISA Kits Product Portfolio
6.13.5 Aviva Systems Biology Recent Developments/Updates
6.14 Biomatik
6.14.1 Biomatik Company Information
6.14.2 Biomatik Description and Business Overview
6.14.3 Biomatik Influenza ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Biomatik Influenza ELISA Kits Product Portfolio
6.14.5 Biomatik Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Influenza ELISA Kits Industry Chain Analysis
7.2 Influenza ELISA Kits Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Influenza ELISA Kits Production Mode & Process
7.4 Influenza ELISA Kits Sales and Marketing
7.4.1 Influenza ELISA Kits Sales Channels
7.4.2 Influenza ELISA Kits Distributors
7.5 Influenza ELISA Kits Customers
8 Influenza ELISA Kits Market Dynamics
8.1 Influenza ELISA Kits Industry Trends
8.2 Influenza ELISA Kits Market Drivers
8.3 Influenza ELISA Kits Market Challenges
8.4 Influenza ELISA Kits Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Influenza ELISA Kits Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Influenza ELISA Kits Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Influenza ELISA Kits Market Competitive Situation by Manufacturers in 2023
Table 4. Global Influenza ELISA Kits Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Influenza ELISA Kits Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Influenza ELISA Kits Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Influenza ELISA Kits Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Influenza ELISA Kits Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Influenza ELISA Kits, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Influenza ELISA Kits, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Influenza ELISA Kits, Product Type & Application
Table 12. Global Key Manufacturers of Influenza ELISA Kits, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Influenza ELISA Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza ELISA Kits as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Influenza ELISA Kits Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Influenza ELISA Kits Sales by Region (2019-2024) & (K Units)
Table 18. Global Influenza ELISA Kits Sales Market Share by Region (2019-2024)
Table 19. Global Influenza ELISA Kits Sales by Region (2025-2030) & (K Units)
Table 20. Global Influenza ELISA Kits Sales Market Share by Region (2025-2030)
Table 21. Global Influenza ELISA Kits Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Influenza ELISA Kits Revenue Market Share by Region (2019-2024)
Table 23. Global Influenza ELISA Kits Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Influenza ELISA Kits Revenue Market Share by Region (2025-2030)
Table 25. North America Influenza ELISA Kits Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Influenza ELISA Kits Sales by Country (2019-2024) & (K Units)
Table 27. North America Influenza ELISA Kits Sales by Country (2025-2030) & (K Units)
Table 28. North America Influenza ELISA Kits Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Influenza ELISA Kits Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Influenza ELISA Kits Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Influenza ELISA Kits Sales by Country (2019-2024) & (K Units)
Table 32. Europe Influenza ELISA Kits Sales by Country (2025-2030) & (K Units)
Table 33. Europe Influenza ELISA Kits Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Influenza ELISA Kits Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Influenza ELISA Kits Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Influenza ELISA Kits Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Influenza ELISA Kits Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Influenza ELISA Kits Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Influenza ELISA Kits Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Influenza ELISA Kits Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Influenza ELISA Kits Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Influenza ELISA Kits Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Influenza ELISA Kits Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Influenza ELISA Kits Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Influenza ELISA Kits Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Influenza ELISA Kits Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Influenza ELISA Kits Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Influenza ELISA Kits Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Influenza ELISA Kits Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Influenza ELISA Kits Sales (K Units) by Type (2019-2024)
Table 51. Global Influenza ELISA Kits Sales (K Units) by Type (2025-2030)
Table 52. Global Influenza ELISA Kits Sales Market Share by Type (2019-2024)
Table 53. Global Influenza ELISA Kits Sales Market Share by Type (2025-2030)
Table 54. Global Influenza ELISA Kits Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Influenza ELISA Kits Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Influenza ELISA Kits Revenue Market Share by Type (2019-2024)
Table 57. Global Influenza ELISA Kits Revenue Market Share by Type (2025-2030)
Table 58. Global Influenza ELISA Kits Price (US$/Unit) by Type (2019-2024)
Table 59. Global Influenza ELISA Kits Price (US$/Unit) by Type (2025-2030)
Table 60. Global Influenza ELISA Kits Sales (K Units) by Application (2019-2024)
Table 61. Global Influenza ELISA Kits Sales (K Units) by Application (2025-2030)
Table 62. Global Influenza ELISA Kits Sales Market Share by Application (2019-2024)
Table 63. Global Influenza ELISA Kits Sales Market Share by Application (2025-2030)
Table 64. Global Influenza ELISA Kits Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Influenza ELISA Kits Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Influenza ELISA Kits Revenue Market Share by Application (2019-2024)
Table 67. Global Influenza ELISA Kits Revenue Market Share by Application (2025-2030)
Table 68. Global Influenza ELISA Kits Price (US$/Unit) by Application (2019-2024)
Table 69. Global Influenza ELISA Kits Price (US$/Unit) by Application (2025-2030)
Table 70. MyBioSource Company Information
Table 71. MyBioSource Description and Business Overview
Table 72. MyBioSource Influenza ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. MyBioSource Influenza ELISA Kits Product
Table 74. MyBioSource Recent Developments/Updates
Table 75. XpressBio Company Information
Table 76. XpressBio Description and Business Overview
Table 77. XpressBio Influenza ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. XpressBio Influenza ELISA Kits Product
Table 79. XpressBio Recent Developments/Updates
Table 80. Abbexa Company Information
Table 81. Abbexa Description and Business Overview
Table 82. Abbexa Influenza ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Abbexa Influenza ELISA Kits Product
Table 84. Abbexa Recent Developments/Updates
Table 85. Sino Biological Company Information
Table 86. Sino Biological Description and Business Overview
Table 87. Sino Biological Influenza ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Sino Biological Influenza ELISA Kits Product
Table 89. Sino Biological Recent Developments/Updates
Table 90. Novus Biologicals Company Information
Table 91. Novus Biologicals Description and Business Overview
Table 92. Novus Biologicals Influenza ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Novus Biologicals Influenza ELISA Kits Product
Table 94. Novus Biologicals Recent Developments/Updates
Table 95. Biorbyt Company Information
Table 96. Biorbyt Description and Business Overview
Table 97. Biorbyt Influenza ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Biorbyt Influenza ELISA Kits Product
Table 99. Biorbyt Recent Developments/Updates
Table 100. DEMEDITEC Diagnostics Company Information
Table 101. DEMEDITEC Diagnostics Description and Business Overview
Table 102. DEMEDITEC Diagnostics Influenza ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. DEMEDITEC Diagnostics Influenza ELISA Kits Product
Table 104. DEMEDITEC Diagnostics Recent Developments/Updates
Table 105. Eagle Bioscience Company Information
Table 106. Eagle Bioscience Description and Business Overview
Table 107. Eagle Bioscience Influenza ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Eagle Bioscience Influenza ELISA Kits Product
Table 109. Eagle Bioscience Recent Developments/Updates
Table 110. Krishgen Biosystems Company Information
Table 111. Krishgen Biosystems Description and Business Overview
Table 112. Krishgen Biosystems Influenza ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Krishgen Biosystems Influenza ELISA Kits Product
Table 114. Krishgen Biosystems Recent Developments/Updates
Table 115. United States Biological Company Information
Table 116. United States Biological Description and Business Overview
Table 117. United States Biological Influenza ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. United States Biological Influenza ELISA Kits Product
Table 119. United States Biological Recent Developments/Updates
Table 120. Abnova Corporation Company Information
Table 121. Abnova Corporation Description and Business Overview
Table 122. Abnova Corporation Influenza ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Abnova Corporation Influenza ELISA Kits Product
Table 124. Abnova Corporation Recent Developments/Updates
Table 125. IBL Company Information
Table 126. IBL Description and Business Overview
Table 127. IBL Influenza ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. IBL Influenza ELISA Kits Product
Table 129. IBL Recent Developments/Updates
Table 130. Aviva Systems Biology Company Information
Table 131. Aviva Systems Biology Description and Business Overview
Table 132. Aviva Systems Biology Influenza ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Aviva Systems Biology Influenza ELISA Kits Product
Table 134. Aviva Systems Biology Recent Developments/Updates
Table 135. Biomatik Company Information
Table 136. Biomatik Description and Business Overview
Table 137. Biomatik Influenza ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Biomatik Influenza ELISA Kits Product
Table 139. Biomatik Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Influenza ELISA Kits Distributors List
Table 143. Influenza ELISA Kits Customers List
Table 144. Influenza ELISA Kits Market Trends
Table 145. Influenza ELISA Kits Market Drivers
Table 146. Influenza ELISA Kits Market Challenges
Table 147. Influenza ELISA Kits Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Influenza ELISA Kits
Figure 2. Global Influenza ELISA Kits Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Influenza ELISA Kits Market Share by Type: 2023 & 2030
Figure 4. IgM Product Picture
Figure 5. IgG Product Picture
Figure 6. Global Influenza ELISA Kits Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Influenza ELISA Kits Market Share by Application: 2023 & 2030
Figure 8. Hospital
Figure 9. Laboratory
Figure 10. Others
Figure 11. Global Influenza ELISA Kits Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Influenza ELISA Kits Market Size (2019-2030) & (US$ Million)
Figure 13. Global Influenza ELISA Kits Sales (2019-2030) & (K Units)
Figure 14. Global Influenza ELISA Kits Average Price (US$/Unit) & (2019-2030)
Figure 15. Influenza ELISA Kits Report Years Considered
Figure 16. Influenza ELISA Kits Sales Share by Manufacturers in 2023
Figure 17. Global Influenza ELISA Kits Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Influenza ELISA Kits Players: Market Share by Revenue in Influenza ELISA Kits in 2023
Figure 19. Influenza ELISA Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Influenza ELISA Kits Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Influenza ELISA Kits Sales Market Share by Country (2019-2030)
Figure 22. North America Influenza ELISA Kits Revenue Market Share by Country (2019-2030)
Figure 23. United States Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Influenza ELISA Kits Sales Market Share by Country (2019-2030)
Figure 26. Europe Influenza ELISA Kits Revenue Market Share by Country (2019-2030)
Figure 27. Germany Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Influenza ELISA Kits Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Influenza ELISA Kits Revenue Market Share by Region (2019-2030)
Figure 34. China Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Influenza ELISA Kits Sales Market Share by Country (2019-2030)
Figure 42. Mexico Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Influenza ELISA Kits Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Influenza ELISA Kits Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Influenza ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Influenza ELISA Kits by Type (2019-2030)
Figure 52. Global Revenue Market Share of Influenza ELISA Kits by Type (2019-2030)
Figure 53. Global Influenza ELISA Kits Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Influenza ELISA Kits by Application (2019-2030)
Figure 55. Global Revenue Market Share of Influenza ELISA Kits by Application (2019-2030)
Figure 56. Global Influenza ELISA Kits Price (US$/Unit) by Application (2019-2030)
Figure 57. Influenza ELISA Kits Value Chain
Figure 58. Influenza ELISA Kits Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
